These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2575 related articles for article (PubMed ID: 15647825)

  • 1. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
    Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
    Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
    Ellison TI; Eckert RL; MacDonald PN
    J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts.
    Yamamoto H; Shevde NK; Warrier A; Plum LA; DeLuca HF; Pike JW
    J Biol Chem; 2003 Aug; 278(34):31756-65. PubMed ID: 12796488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
    Barletta F; Freedman LP; Christakos S
    Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
    Dhawan P; Peng X; Sutton AL; MacDonald PN; Croniger CM; Trautwein C; Centrella M; McCarthy TL; Christakos S
    Mol Cell Biol; 2005 Jan; 25(1):472-87. PubMed ID: 15601867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C; Jehan F; DeLuca HF
    Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 129.